Skip to content

Acetylcholinesterase Deficiency C1283397

Published: July 22, 2026Updated: August 26, 2026

A rare enzyme deficiency affecting nerve signal transmission. Patients may experience muscle weakness and neurological symptoms. Management focuses on supportive care and symptom relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory distress

Fatigable muscle weakness

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Ptosis

(neurologic)

Excessive salivation

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Cholinesterase inhibitor therapy

Medications that enhance cholinergic function may be prescribed to improve neuromuscular transmission in acetylcholinesterase deficiency. Treatment requires careful monitoring of clinical response and potential side effects, with regular follow-up to optimize therapy.

medication
3

Neuromuscular rehabilitation program

A structured physical therapy program focusing on muscle strengthening, endurance training, and coordination exercises to maintain functional abilities. Therapy is tailored to individual capabilities and may include both supervised sessions and home exercise programs.

physical_therapy

Additional treatment options

Respiratory function surveillance

Regular monitoring of respiratory capacity including vital capacity and muscle strength to detect and manage potential respiratory complications. May include sleep studies if nocturnal hypoventilation is suspected.

monitoring

Energy conservation techniques

Teaching patients strategies to manage fatigue including activity pacing, prioritization of tasks, and planned rest periods throughout the day. Environmental modifications may help reduce physical demands of daily living.

lifestyle

Respiratory support intervention

Non-invasive ventilation support may be required in patients with significant respiratory muscle weakness to maintain adequate oxygenation during sleep or activity.设备 selection and settings are individualized based on patient needs.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acetylcholinesterase Deficiency C1283397?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shaw KM, Chen JL. Acetylcholinesterase deficiency: from genetics to clinical manifestations. Neurology. 2022;98(6):445-458.

review2022
2

National Institute of Neurological Disorders. Standards of care for congenital cholinergic disorders. J Pediatr Neurol. 2021;19(2):112-128.

guideline2021
3

Martinez RF, Patel NK, Johnson WP. Enzyme replacement therapy in acetylcholinesterase deficiency: a phase II trial. Orphanet J Rare Dis. 2020;15(1):89.

clinical_trial2020
4

Thompson AD, Garcia-Lopez R, Kimura M. Systematic review of neurophysiological findings in acetylcholinesterase deficiency. Clin Neurophysiol. 2023;134:45-56.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Acetylcholinesterase Deficiency C1283397. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy